EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease

EphA2 Is a Clinically Relevant Target for Breast Cancer Bone Metastatic Disease

ABSTRACT EphA2 receptor tyrosine kinase (RTK) is highly expressed in breast tumor cells across multiple molecular subtypes and correlates with poor patient prognosis. In this study, the potential role of EphA2 in this clinically relevant phenomenon is investigated as metastasis of breast cancer to b...

Full description

Bibliographic Details
Main Authors: David B Vaught, Alyssa R Merkel, Conor C Lynch, James Edwards, Mohammed Noor Tantawy, Timothy Hilliard, Shan Wang, Todd Peterson, Rachelle W Johnson, Julie A Sterling, Dana Brantley‐Sieders
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:JBMR Plus
Subjects:
ANIMAL MODELS
BONE CELLS
CANCER
OSTEOCLASTS
PRECLINICAL STUDIES
THERAPEUTICS
Online Access:https://doi.org/10.1002/jbm4.10465

Internet

https://doi.org/10.1002/jbm4.10465

Similar Items